Get started
Author

Daniel Chan

Observed names: D Chan, D. Chan, Daniel Z L Chan, Daniel Z. L. Chan, Daniel Z.L. Chan, Daniel ZL Chan, Daniel ZL. Chan
Observed institutions: University of Auckland, The University of Western Australia, Middlemore Hospital, Auckland City Hospital, University Hospitals of Leicester NHS Trust, Cardiac Society of Australia and New Zealand, Northland District Health Board, Counties Manukau District Health Board, Auckland District Health Board, Health New Zealand
ORCID: 0000-0002-1201-6187
Observed ORCID: 0000-0002-1201-6187
OpenAlex ID: A5078939311
Temporal trends in the burden of heart failure
2021 · Daniel Z. L. Chan, Andrew J. Kerr, et al. · Internal Medicine Journal · 33
The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55)
2020 · Daniel ZL. Chan, Ralph AH. Stewart, et al. · The Lancet Regional Health - Western Pacific · 33
PDF
Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018
2021 · Daniel Z L Chan, Andrew Kerr, et al. · Heart · 25
Validation Study of Cardiovascular International Statistical Classification of Diseases and Related Health Problems, Tenth Edition, Australian Modification (ICD-10-AM) Codes in Administrative Healthcare Databases (ANZACS–QI 77)
2024 · Daniel Z.L. Chan, Andrew J. Kerr, et al. · Heart Lung and Circulation · 14
Widening ethnic inequities in heart failure incidence in New Zealand
2023 · Daniel ZL Chan, Corina Grey, et al. · Heart · 14
Diagnostic coronary angiography and percutaneous coronary intervention practices in New Zealand: The All New Zealand Acute Coronary Syndrome-Quality Improvement CathPCI registry 3-year study (ANZACS-QI 37)
2020 · Tom Kai Ming Wang, Chethan Kasargod, et al. · International Journal of Cardiology · 8
2023 position statement on improving management for patients with heart failure in Aotearoa New Zealand
2024 · Robert Doughty, Gerry Devlin, et al. · New Zealand Medical Journal · 5
PDF
What is the Statin Possession Ratio Cut-Off Which Identifies Those at Increased Risk Following Acute Coronary Syndrome (ANZACS-QI 68)?
2023 · Morisha Ali, Andrew J. Kerr, et al. · Heart Lung and Circulation · 5
PDF
What is the Optimal Rate of Invasive Coronary Angiography After Acute Coronary Syndrome? (ANZACS-QI 22)
2019 · Daniel Chan, Samia Ghazali, et al. · Heart Lung and Circulation · 5
Validation of Heart Failure Discharge Coding Utilising the PEOPLE Study and ADHF Registry
2021 · D. Chan, K. Poppe, et al. · Heart Lung and Circulation · 4
Short, Medium and Long-Term Cause-Specific Mortality Following First-Ever Heart Failure Hospitalisation in New Zealand
2024 · Daniel Z.L. Chan, Rob N. Doughty, et al. · Heart Lung and Circulation · 3
Identification of clinically relevant cohorts of people with heart failure from electronic health data in Aotearoa: potential, pitfalls and a plan
2022 · Rob Doughty, Vanessa Selak, et al. · New Zealand Medical Journal · 3
PDF
Prognostic significance of mid-range ejection fraction following acute coronary syndrome (ANZACS-QI 23).
2021 · Daniel Chan, Robert N Doughty, et al. · PubMed · 3
Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34)
2020 · Daniel Chan, Robert N. Doughty, et al. · Heart Lung and Circulation · 3
PDF
https://nzmj.org.nz/journal/vol-137-no-1599/use-of-medications-for-migraine-in-aotearoa-new-zealand
2024 · Daniel Chan, Robert Doughty, et al. · New Zealand Medical Journal · 2
PDF
Heart failure clinics improve use of evidence-based heart failure therapies in patients with reduced ejection fraction following acute coronary syndrome (ANZACS-QI 48).
2020 · Daniel Chan, Robert N Doughty, et al. · PubMed · 1
Not all mitral stenosis are due to valve disease.
2019 · Daniel Chan, Charles Yao-Cheng Ho, et al. · PubMed · 1
Percutaneous Coronary Intervention for Left Main Coronary Disease in New Zealand: National Linkage Study of Characteristics and In-Hospital Outcomes (ANZACS-QI 38)
2019 · Tom Kai Ming Wang, Andrew Kerr, et al. · Cardiovascular revascularization medicine · 1
TCT-1238 The Contemporary Peri-Procedural Complication Rate of Invasive Diagnostic Coronary Angiography in New Zealand: A Review of ANZACS-QI Database 2014–2022
2025 · Tim Oh, Ammar Alsamarrai, et al. · Journal of the American College of Cardiology
ANZACS-QI Heart Failure Registry—Improving Heart Failure Care in New Zealand
2025 · D. Chan, A. Easton, et al. · Heart Lung and Circulation
Feasibility, efficacy and safety of early and rapid initiation of evidence-based treatment for patients with HFrEF- a real world experience of the "four drugs in four weeks" strategy
2023 · S Sze, C Thaitirarot, et al. · European Heart Journal
PDF
An Audit of Inpatient Management of Acute Decompensated Heart Failure With Reduced Ejection Fraction in General Medicine
2023 · A. Sun, J. He, et al. · Heart Lung and Circulation
123 Early and rapid initiation of hfref pharmacotherapy - a real world experience of a "4 drugs in 4 weeks" strategy
2022 · Chokanan Thaitirarot, Bonnie Cheung, et al. · Heart
PDF
What is the Statin Possession Ratio Cut-off Which Identifies Those at Increased Risk Following Acute Coronary Syndrome (ANZACS-QI 68)
2022 · Morisha Ali, Andrew Kerr, et al. · Heart Lung and Circulation
PDF
Clinical Characteristics and Management of Patients With Ischaemic Cardiomyopathy Undergoing Cardiac Magnetic Resonance Imaging at Middlemore Hospital: A Single-Centre Experience
2021 · M. Ali, D. Chan, et al. · Heart Lung and Circulation
Works count: 34
Citation count: 163
H-index: 6
I10-index: 5
Year
Topic
Type